TRICON
RxNorm 999799· ORAL
Vitamin C [EPC], Vitamin B12 [EPC] · Nnodum Pharmaceuticals
Indications and usage
INDICATIONS AND USAGE TRICON™ is a multifactor preparation effective in the treatment of anemias that respond to oral hematinics, including pernicious anemia and other megaloblastic anemias and also irondeficiency anemia. Therapeutic quantities of hematopoietic factors that are known to be important are present in the recommended daily dose.
Dosage and administration
DOSAGE AND ADMINISTRATION One capsule twice a day. (Two capsules daily produce a standard response in the average uncomplicated case of pernicious anemia.)
Contraindications
CONTRAINDICATIONS Hemochromatosis and hemosiderosis are contraindications to iron therapy.
Pregnancy
Pregnancy Teratogenic Effects Pregnancy Category C: Animal reproduction studies have not been conducted with TRICON™ Capsules. It is also not known whether TRICON™ Capsules can cause fetal harm when administered to pregnant women or can affect reproduction capacity. TRICON™ Capsules should be given to pregnant women only if clearly needed.
Nursing mothers
Nursing Mothers It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when TRICON™ is administered to a nursing woman.
Adverse events
Most frequently reported events (FDA FAERS). Report frequency does not imply causation.
- death2
- headache2
- abdominal pain1
- activities of daily living impaired1
- acute kidney injury1
- cataract1
- chronic kidney disease1
- drug ineffective1
- dysaesthesia1
- eye irritation1
- eye pain1
- eyelid irritation1
- fatigue1
- foreign body sensation in eyes1
- gait disturbance1
- heart rate irregular1
Adverse reactions (label)
ADVERSE REACTIONS Rarely, iron in therapeutic doses produces gastrointestinal reactions, such as diarrhea or constipation. Reducing the dose and administering it with meals will minimize these effects in the iron-sensitive patient. In extremely rare instances, skin rash suggesting allergy has been noted following the oral administration of liver-stomach material. Allergic sensitization has been reported following both oral and parenteral administration of folic acid.
KR · 한국Products in Korea (532)
- 헤모로얄캡슐(유)한풍제약
- 헤모로얄캡슐(유)한풍제약
- 에나스캅셀(주)경인제약
- 제라텐캡슐(주)넥스팜코리아
- 제라텐캡슐(주)넥스팜코리아
- 훼리너프캡슐(주)녹십자
- 훼리너프캡슐(주)녹십자
- 훼리너프캡슐(주)녹십자
- 훼리너프에프캡슐(주)녹십자
- 훼리너프에프캡슐(주)녹십자
- 녹십자폴산정(주)녹십자
- 녹십자폴산정(주)녹십자
- 가스롤산(주)다림바이오텍
- 가스롤캅셀(주)다림바이오텍
- 폴다정5밀리그램(폴산)(주)다림바이오텍
- 폴다정5밀리그램(폴산)(주)다림바이오텍
- 폴다정5밀리그램(폴산)(주)다림바이오텍
- 폴다정5밀리그램(폴산)(주)다림바이오텍
- 글루비타정(주)다림바이오텍
- 글루비타정(주)다림바이오텍
View more: Full FDA label on DailyMed →Label effective 20251229